To exclude the possibility that anti-obesity effects of PCPA might be related to the inhibition of 5-HT synthesis in the brain, we have tested peripheral Tph inhibitior, LP-533401, which cannot cross the blood–brain barrier14. Here, TPH1 is linked to obesity disorder.